Stroke trials in Japan
11 of 14 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleRecombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
- Where
- Fukuoka, Gifu, Kagoshima, Kobe, Kyoto, Niigata, Osaka, Sapporo, Shimotsuke, Suita, Tokyo
- Age
- 18 years to 80 years
- People
- 350 worldwide
- Run by
- Joseph Broderick, MD
See details and how to joinNCT07227246 - No phaseTaking peoplePemafibrate for Symptomatic ICAS RCT
- Where
- Adachi-ku, Bunkyo-ku, Chūō, Fukuyama, Hidaka, Hirakata, Hiroshima, Hizume, Isehara, Kagoshima, Kawasaki, Kobe, Kodaira, Koto-ku, Kumamoto, Kurashiki, Kyoto, Mibu, Minato-Ku, Mitaka, Nagasaki, Osaka, Ōta-ku, Saitama, Sakai, Shimotsuke, Shinjuku-ku, Suita, Tama, Tokushima, Toyoake, Tsukuba, Yachiyo, Yoshida
- Age
- 18 years and over
- People
- 270
- Run by
- Tokyo Women's Medical University
See details and how to joinNCT07562178 - Phase 3Taking peopleStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Where
- Higashiibaraki District, Kanagawa, Kawanishi, Kyoto, Sapporo, Tsuchiura, Yokohama
- Age
- 18 years and over
- People
- 15,364 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07626411 · EU 2025-521617-97-00 - Phase 3Taking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Chūōku, Hamadayama, Suginami-ku, Izumisano, Kobe, Kofu, Kumamoto, Shinjuku-ku, Takarazuka, Uji, Wakayama
- Age
- 50 years and over
- People
- 7,140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - Phase 2/3Taking peopleOptimizing Reperfusion to Improve Outcomes and Neurologic Function
- Where
- Fukuoka, Hyōgo, Ibaraki, Kamakura, Meguro City, Mitaka, Miyagi, Toyota, Yamagata, Yamaguchi
- Age
- 18 years to 90 years
- People
- 740 worldwide
- Run by
- Corxel Pharmaceuticals
See details and how to joinNCT06990867 - Phase 2Taking peopleA Study of TAK-755 in Adults With Acute Ischemic Stroke
- Where
- Fukuoka, Izumisano, Nagano, Osaka
- Age
- 18 years and over
- People
- 222 worldwide
- Run by
- Takeda
See details and how to joinNCT07392450 - Phase 4Taking peopleLacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial
- Where
- Chūō, Fukui, Fukuoka, Fukuyama, Hirakata, Kagoshima, Katsuura, Kawasaki, Komae, Kurashiki, Kyoto, Minatoku, Okayama, Osaka, Sendai, Shimotsuke, Tama, Tochigi, Tokushima, Tokyo, Ube, Urayasu
- Age
- 18 years and over
- People
- 500
- Run by
- Nippon Medical School
See details and how to joinNCT07111559 - Phase 1/2Taking peopleA Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
- Where
- Fukuoka, Shizuoka, Tokushima, Tokyo
- Age
- 18 years to 70 years
- People
- 240 worldwide
- Run by
- Ipsen
See details and how to joinNCT04752774 · EU 2023-507202-14-00 - No phaseTaking peopleRandomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the M2 Segment of Middle Cerebral Artery
- Where
- Nishinomiya
- Age
- 18 years to 84 years
- People
- 200 worldwide
- Run by
- Hyogo Medical University
See details and how to joinNCT07347665 - Phase 1/2Taking peopleA Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke
- Where
- Bunkyo-ku, Kyoto, Sendai, Tokushima, Toyama
- Age
- 18 years to 80 years
- People
- 84
- Run by
- Astellas Pharma Inc
See details and how to joinNCT07318714 - Phase 2Taking peopleIntracerebral Autologous Stem Cell Therapy for Chronic Stroke Patients
- Where
- Sapporo
- Age
- 20 years to 70 years
- People
- 8
- Run by
- Hokkaido University Hospital
See details and how to joinNCT06752720